Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 References  













Zaltoprofen






●فارسی
 ●日本語
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  



In other projects  


●Wikimedia Commons
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Zaltoprofen
Clinical data
Trade namesSoleton
Other namesZaxoprofen
Drug classNSAID
Legal status
Legal status
  • US: Not FDA approved
  • Japan: Rx-only
    • Identifiers

    • 2-(6-Oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid

    CAS Number
    PubChem CID
    DrugBank
    UNII
    CompTox Dashboard (EPA)
    ECHA InfoCard100.070.863 Edit this at Wikidata
    Chemical and physical data
    FormulaC17H14O3S
    Molar mass298.36 g·mol−1
    3D model (JSmol)

    • CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O

    Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]

    It was approved for use in Japan in 1993.[3]

    References[edit]

    1. ^ "Zaltoprofen". drugs.com.
  • ^ Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424. S2CID 27367042.
  • ^ "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.


    • Stub icon

    This analgesic-related article is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Zaltoprofen&oldid=1205033063"
    Categories: 
    ●COX-2 inhibitors
     ●Nonsteroidal anti-inflammatory drugs
     ●Carboxylic acids
     ●Analgesic stubs
     Hidden categories: 
    ●Articles with short description
     ●Short description is different from Wikidata
     ●Drugs with non-standard legal status
     ●ECHA InfoCard ID from Wikidata
     ●Articles without EBI source
     ●Chemical pages without ChemSpiderID
     ●Articles without KEGG source
     ●Articles without InChI source
     ●Drugs missing an ATC code
     ●Articles containing unverified chemical infoboxes
     ●All stub articles
      


    ●This page was last edited on 8 February 2024, at 17:51 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki